Implant for Walking After Stroke

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-16

Study Completion Date

2027-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a device study that will evaluate the effect of an implanted stimulator on improving walking in stroke survivors. There are two phases in the study: 1) Screening - this phase determines if the individual is a good candidate to receive an implanted system, 2) Implantation, controller development, and evaluation - this phase includes installing the device and setting the individual up for home use, creating advanced controllers for walking and evaluating the effect of the device over several months.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Treatments for Recovery of Hand Function in Acute Stroke Survivors

NCT00565045

Stroke, Acute Stroke Hemiparesis +1 more

COMPLETED PHASE1/PHASE2

Brain and Coordination Changes Induced By Robotics and FES Treatment Following Stroke

NCT00237744

Cerebral Stroke Cerebrovascular Accident Stroke

COMPLETED NA

Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Arm Function After Stroke

NCT03592745

Stroke Cerebrovascular Accident (CVA) Hemiparesis

COMPLETED PHASE2

Electrical Stimulation for Recovery of Ankle Dorsiflexion in Chronic Stroke Survivors

NCT01029912

Stroke Hemiparesis Lower Extremity Paresis

COMPLETED NA

Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke

NCT00142792

Stroke, Acute Stroke Hemiparesis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to evaluate the effects of neural stimulation for improving walking after stroke. Participants will undergo surgery to implant a stimulator and electrodes to activate muscles used during walking. The device delivers electrical pulses to the nerves causing the muscles to contract to perform functional movements. The system coordinates assistance based on external sensors. After receiving the implanted device, participants undergo training to use the device to assist walking. Evaluations are completed prior to surgery as well after training and at later follow up sessions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Hemiplegia Gait, Hemiplegic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Implantation, controller development, and evaluation

This phase includes installing the device and setting the individual up for home use, creating advanced controllers for walking and evaluating the effect of the device over several months.

Group Type EXPERIMENTAL

IRS-8

Intervention Type DEVICE

Implanted Receiver Stimulator (IRS) delivering 8 channels of stimulation. Appropriate for muscle-based (intramuscular or epimysial) electrodes only

IST 12 & IST 16

Intervention Type DEVICE

Implantable Stimulator Telemeter (IST) that provides 12 independent channels of stimulation with the option of 2 channels of bipolar myoelectric signal recording, or 16 independent stimulus channels. Suitable for muscle-based or nerve cuff electrodes such as the CWRU Spiral, Flat Interface Nerve Electrode (FINE) or Composite-Flat Interface Nerve Electrode (C-FINE).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IRS-8

Implanted Receiver Stimulator (IRS) delivering 8 channels of stimulation. Appropriate for muscle-based (intramuscular or epimysial) electrodes only

Intervention Type DEVICE

IST 12 & IST 16

Implantable Stimulator Telemeter (IST) that provides 12 independent channels of stimulation with the option of 2 channels of bipolar myoelectric signal recording, or 16 independent stimulus channels. Suitable for muscle-based or nerve cuff electrodes such as the CWRU Spiral, Flat Interface Nerve Electrode (FINE) or Composite-Flat Interface Nerve Electrode (C-FINE).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 6-months post stroke
* Age 21 to 75 years old
* Able to ambulate, but does not require the assistance of more than one person
* Walk slower than 0.8m/s during a 10m walk test
* Lower extremity Fugl-Meyer Motor Assessment (FMA) \<= 20
* Reduced peak hip, knee and/or ankle range of motion during stance or swing phases
* Modified Ashworth Scale (MAS) \<= 2 at the above joints during passive flexion and extension
* Innervated and excitable lower extremity and trunk musculature
* Appropriate body habitus (height and weight within acceptable limits as determined by study physician)
* Adequate social support and stability
* Willingness to comply with follow-up procedures
* Neurologically stable as determined by a physician

Exclusion Criteria

* Non-English speaking
* Significant range of motion limitations (lacking hip extension, etc.)
* History of spontaneous fractures or other evidence of excessively low bone density
* Acute orthopedic problems (severe scoliosis, joint dislocations, etc.)
* Medical complications (cardiac abnormalities, skin breakdowns, uncontrolled seizures, immunological/pulmonary/renal/circulatory compromise, additional neurologic conditions etc.)
* Cardiovascular or pulmonary disease
* Uncontrolled diabetes or hypertension
* Presence of a demand pacemaker or cardiac defibrillator
* Pregnancy
* Complications of stroke that result in an increased risk of falls (apraxia, uncompensated hemineglect, hemianopsia etc.)
* Significant history of repeated falls
* Severely impaired cognition and communication
* Any other medical or psychological condition that would be a contraindication

Minimum Eligible Age

21 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No